Ola Weiland (O Weiland)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Venues

Journal of viral hepatitis

The European journal of health economics : HEPAC : health economics in prevention and care

Infectious diseases (London, England)

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet

Sweden

Professor, senior consultant, MD :: Medicine, Div. of ID

Publications

Peter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, Ola Weiland, Bengt Jönsson
Value appropriation in hepatitis C. The European journal of health economics : HEPAC : health economics in prevention and care (2021)
Peter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, Ola Weiland
Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antivirals. Journal of viral hepatitis 28 (1) (2020)
Martin Kåberg, Georg Navér, Anders Hammarberg, Ola Weiland
Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination. Journal of viral hepatitis 25 (12) (2018)
Magnus Hedenstierna, A Nangarhari, A El-Sabini, Ola Weiland, S Aleman
Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C. Journal of viral hepatitis 25 (7) (2018)
Martin Lagging, Rune Wejstål, Ann-Sofi Duberg, Soo Aleman, Ola Weiland, Johan Westin, null null
Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017. Infectious diseases (London, England) 50 (8) (2018)
Steven Flamm, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen Rockstroh, Yves Horsmans, Paul Y Kwo, Ola Weiland, Erica Villa, Jeong Heo, Edward Gane, Stephen D Ryder, Tania M Welzel, Peter J Ruane, Geoffrey Dusheiko, Teresa I Ng, Zhenyi Xue, Sandra S Lovell, Preethi Krishnan, Sarah Kopecky-Bromberg, Roger Trinh, Federico J Mensa, David L Wyles
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis. Journal of viral hepatitis 26 (3) (2018)

Ola Weiland.css-eqlu8i{font-size:small;padding-left:4px;} (O Weiland)

Publication Activity (10 Years)

Top Topics

Top Venues

Ola Weiland (O Weiland)